Rebecca Heichel
Physician Assistant · Longwood, FLNPI 1619380623
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,967 of the $2,266 with a category attached, or 86.8%. It is spread thinly across 28 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $926 and has fallen 55.2% since, to $415 in 2025.
Across 72 payments — averaging $31.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$305
- Incyte Corporation$255
- UCB, Inc.$244
- E.r. Squibb & Sons, L.L.C.$190
- AbbVie$153
- AstraZeneca$135
- plus $984 from 22 others
What the payments were for
- Food & beverage$1,96787%
- Education$29913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $305 |
| Incyte Corporation | 5 | $255 |
| UCB, Inc. | 9 | $244 |
| E.r. Squibb & Sons, L.L.C. | 4 | $190 |
| AbbVie | 3 | $153 |
| AstraZeneca(2 entities) | 5 | $135 |
| Merck | 5 | $132 |
| Sanofi | 1 | $122 |
| Novartis | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Sobi, Inc | 2 | $63 |
| Genentech USA, Inc. | 3 | $62 |
| Lilly USA, LLC | 2 | $59 |
| Taiho Oncology, Inc. | 3 | $59 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Novocure Inc. | 1 | $36 |
| Beigene USA, Inc. | 2 | $31 |
| Eisai Inc. | 2 | $30 |
| Bristol Myers Squibb | 1 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Beone Medicines USA, Inc. | 1 | $21 |
| Seagen Inc. | 1 | $20 |
| Array Biopharma Inc | 1 | $20 |
| Exelixis Inc. | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,266 in reported general payments places this provider in the 75th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $15,394 |
| Anastrozole | 22 | $633 |
| Acyclovir | 13 | $437 |
| Ciprofloxacin Hcl | 11 | $100 |
| Prednisone | 15 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $15,39420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Longwood
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
- Nicole HillOrlando$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.